- $1.56bn
- $1.21bn
- $367.25m
- 66
- 46
- 15
- 37
Annual income statement for Ibotta, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 211 | 320 | 367 |
Cost of Revenue | |||
Gross Profit | 165 | 276 | 317 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | 251 | 264 | 349 |
Operating Profit | -40.3 | 56 | 18.2 |
Total Net Non Operating Interest Income / Expense | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -54.6 | 44.1 | 24.5 |
Provision for Income Taxes | |||
Net Income After Taxes | -54.9 | 38.1 | 68.7 |
Net Income Before Extraordinary Items | |||
Net Income | -54.9 | 38.1 | 68.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -54.9 | 38.1 | 68.7 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -1.7 | 1.27 | 2.81 |